Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subtherapeutic-dose esketamine for preventive analgesia in children with obstructive sleep apnea syndrome undergoing surgery
ChiCTR2600135115Phase 4Not yet recruiting
- Sponsor
- Kaifeng Children's Hospital
- Start
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain (2 arms), sponsored by Kaifeng Children's Hospital. Primary endpoint: Number of cases with inadequate analgesia in the PACU. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600135115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135115.